The researchers showed for the first time that BCR::ABL1 transcripts could be detected in exosomes circulating in CML patients’ PB, even in cases of patients under TKIs treatment and presenting undetectable MRD levels (50). This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.